Morgan Stanley Evotec Se Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Evotec Se stock. As of the latest transaction made, Morgan Stanley holds 385,214 shares of EVO stock, worth $1.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

385,214

Previous 88,041 337.54%

Holding current value

$1.51 Million

Previous $294,000 450.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$2.97 - $4.73 $882,603 - $1.41 Million	297,173 Added 337.54%	385,214 $1.62 Million
Q1 2025 May 15, 2025	SELL	$3.31 - $4.71 $125,382 - $178,414	-37,880 Reduced 30.08%	88,041 $294,000
Q4 2024 Feb 14, 2025	BUY	$2.91 - $5.55 $10,088 - $19,241	3,467 Added 2.83%	125,921 $523,000
Q3 2024 May 14, 2025	BUY	$2.96 - $5.34 $1,906 - $3,438	644 Added 0.53%	122,454 $446,000
Q3 2024 Nov 14, 2024	BUY	$2.96 - $5.34 $1,906 - $3,438	644 Added 0.53%	122,454 $446,000
Q2 2024 May 14, 2025	SELL	$4.07 - $7.87 $16,731 - $32,353	-4,111 Reduced 3.26%	121,810 $584,000
Q2 2024 Oct 17, 2024	BUY	$4.07 - $7.87 $139,210 - $269,185	34,204 Added 39.04%	121,810 $584,000
Q2 2024 Aug 14, 2024	BUY	$4.07 - $7.87 $139,210 - $269,185	34,204 Added 39.04%	121,810 $584,000
Q1 2024 Oct 17, 2024	SELL	$6.89 - $11.4 $235,665 - $389,925	-34,204 Reduced 28.08%	87,606 $685,000
Q1 2024 Aug 16, 2024	BUY	$6.89 - $11.4 $302,464 - $500,448	43,899 Added 100.44%	87,606 $685,000
Q1 2024 May 15, 2024	BUY	$6.89 - $11.4 $302,464 - $500,448	43,899 Added 100.44%	87,606 $685,000
Q4 2023 Aug 16, 2024	SELL	$8.33 - $11.89 $650,597 - $928,644	-78,103 Reduced 64.12%	43,707 $512,000
Q4 2023 Feb 13, 2024	SELL	$8.33 - $11.89 $203,260 - $290,127	-24,401 Reduced 35.83%	43,707 $512,000
Q3 2023 Nov 15, 2023	BUY	$9.63 - $13.36 $147,204 - $204,220	15,286 Added 28.94%	68,108 $672,000
Q2 2023 Aug 14, 2023	BUY	$8.95 - $12.48 $53,932 - $75,204	6,026 Added 12.88%	52,822 $596,000
Q1 2023 May 15, 2023	BUY	$8.11 - $10.53 $2,408 - $3,127	297 Added 0.64%	46,796 $489,000
Q4 2022 Feb 14, 2023	BUY	$7.8 - $9.85 $12,659 - $15,986	1,623 Added 3.62%	46,499 $376,000
Q3 2022 Nov 14, 2022	BUY	$8.4 - $28.4 $22,638 - $76,538	2,695 Added 6.39%	44,876 $395,000
Q2 2022 Oct 27, 2022	BUY	$10.78 - $15.5 $111,346 - $160,099	10,329 Added 32.43%	42,181 $505,000
Q2 2022 Aug 15, 2022	BUY	$10.78 - $15.5 $111,346 - $160,099	10,329 Added 32.43%	42,181 $505,000
Q1 2022 Oct 27, 2022	SELL	$12.93 - $23.46 $133,553 - $242,318	-10,329 Reduced 24.49%	31,852 $482,000
Q1 2022 May 13, 2022	SELL	$12.93 - $23.46 $32,790 - $59,494	-2,536 Reduced 7.37%	31,852 $482,000
Q4 2021 Feb 14, 2022	BUY	$22.0 - $25.77 $756,536 - $886,178	34,388 New	34,388 $816,000

Others Institutions Holding EVO

# of Institutions

Shares Held

3.79M

Call Options Held

Put Options Held

View Full List

About Evotec SE

Ticker EVO
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 353,904,992
Market Cap $1.39B
Description
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...

More about EVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account